These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 10622122)
1. [Search for new tuberculosis vaccines]. Gicquel B Bull Acad Natl Med; 1999; 183(7):53-61; discussion 61-2. PubMed ID: 10622122 [TBL] [Abstract][Full Text] [Related]
2. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium. de Lisle GW; Wards BJ; Buddle BM; Collins DM Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030 [TBL] [Abstract][Full Text] [Related]
5. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs. Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606 [TBL] [Abstract][Full Text] [Related]
6. The use of mutant mycobacteria as new vaccines to prevent tuberculosis. Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route. Gupta A; Geetha N; Mani J; Upadhyay P; Katoch VM; Natrajan M; Gupta UD; Bhaskar S Infect Immun; 2009 Jan; 77(1):223-31. PubMed ID: 18981249 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine. Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160 [TBL] [Abstract][Full Text] [Related]
10. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250 [TBL] [Abstract][Full Text] [Related]
11. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice. Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431 [TBL] [Abstract][Full Text] [Related]
12. Animal models for experimental tuberculosis. Smith D; Wiegeshaus E; Balasubramanian V Clin Infect Dis; 2000 Sep; 31 Suppl 3():S68-70. PubMed ID: 11010825 [TBL] [Abstract][Full Text] [Related]
13. Immunoprophylaxis of tuberculosis: an update of emerging trends. Singhal N; Bisht D; Joshi B Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):97-106. PubMed ID: 20140756 [TBL] [Abstract][Full Text] [Related]
14. What's new in tuberculosis vaccines? Ginsberg AM Bull World Health Organ; 2002; 80(6):483-8. PubMed ID: 12132007 [TBL] [Abstract][Full Text] [Related]
16. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518 [TBL] [Abstract][Full Text] [Related]
17. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523 [TBL] [Abstract][Full Text] [Related]
18. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine. Wards BJ; de Lisle GW; Collins DM Tuber Lung Dis; 2000; 80(4-5):185-9. PubMed ID: 11052907 [TBL] [Abstract][Full Text] [Related]
19. Vaccination of cattle against Mycobacterium bovis. Buddle BM Tuberculosis (Edinb); 2001; 81(1-2):125-32. PubMed ID: 11463233 [TBL] [Abstract][Full Text] [Related]
20. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis. Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]